Tildren Injection, 500 mg

Supplied By: Bimeda (1TIL004)


SKU
054624


Unit of
Measure
30 mL


Pack
Type
Vial


Case
Qty
12

{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Dec- 2025 Nov- 2025 Oct- 2025 Sep- 2025 Aug- 2025 Jul- 2025 Jun- 2025 May- 2025 Apr- 2025 Mar- 2025 Feb- 2025 Jan- 2025 Dec- 2024
{{purchaseHistoryItem}}


SKU
054624


Size
30 mL

Case
Qty
12

Purchase History

Dec- 2025 {{productPurchaseHistory['054624'][0]}} May- 2025 {{productPurchaseHistory['054624'][0+7]}}
Nov- 2025 {{productPurchaseHistory['054624'][1]}} Apr- 2025 {{productPurchaseHistory['054624'][1+7]}}
Oct- 2025 {{productPurchaseHistory['054624'][2]}} Mar- 2025 {{productPurchaseHistory['054624'][2+7]}}
Sep- 2025 {{productPurchaseHistory['054624'][3]}} Feb- 2025 {{productPurchaseHistory['054624'][3+7]}}
Aug- 2025 {{productPurchaseHistory['054624'][4]}} Jan- 2025 {{productPurchaseHistory['054624'][4+7]}}
Jul- 2025 {{productPurchaseHistory['054624'][5]}} Dec- 2024 {{productPurchaseHistory['054624'][5+7]}}
Jun- 2025 {{productPurchaseHistory['054624'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

Tildren® is a bisphosphonate drug for intravenous infusion in horses. Tildren is indicated for the control of clinical signs associated with navicular syndrome in horses. Navicular syndrome is the most common cause of chronic forelimb lameness in performance horses. It is a degenerative process instigated by mechanical forces.

Features & Benefits

  • Restores balance to the process of bone remodeling
  • Decreases mineral loss and slows the rate of bone turnover
  • Alleviates pain induced by abnormal osteolysis